INBX Financials
Inhibrx Biosciences Inc - Financial statements & key metrics
Stock Price
$88.23
Market Cap
$1.21B
EPS
$-9.04
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$200,000
Gross Profit
-
Operating Income
-
Net Income
$1.69B
EPS (Diluted)
$112.62
Balance Sheet Highlights
Total Assets
$180.77M
Total Liabilities
$47.18M
Shareholders Equity
-
Cash & Equivalents
$152.60M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-194.41M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-8594.5%
Operating Margin
-103.9%
ROE
-2.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is INBX revenue?
INBX's most recent quarterly revenue was $200,000. Annual revenue can be calculated by summing the four most recent quarters.
Is INBX profitable?
INBX reported a profit of $1.69B in the most recent quarter.
What is INBX market cap?
INBX has a market capitalization of $1.21B, making it a small-cap stock.
Does INBX have debt?
View INBX's balance sheet for debt information.
What is INBX cash flow?
Cash flow data is available in the full financial statements.